25-27 September 2018, Seville, Spain
The Spanish Bioindustry Association (ASEBIO) and the Regional Government of Andalusia have announced a collaboration agreement naming Seville as the site of the ninth BIOSPAIN biennial fair. Between 25 and 27 September 2018, the FIBES Exhibition & Congress Centre will thus be the stage for BIOSPAIN, a forum to exchange knowledge, ideas and experiences among all the actors from the biotech sector, which has become the leading platform to enhance the international standing of Spanish biotechnology.
BIOSPAIN is organised by ASEBIO and by the local and regional governments of the autonomous communities which host the event. For the 2018 fair, ASEBIO is co-organising the event with the Regional Government of Andalusia. To do so, a steering committee has been created with representatives from the Regional Ministries of Knowledge, Research and University; Health; Employment, Enterprise and Commerce; and Agriculture, Rural Development and Fisheries. This steering committee is led by the Innovation and Development Agency of Andalusia (IDEA) with the direct participation of the Regional Ministry of Agriculture, as well as the Andalusian Knowledge Agency and Progress and Health Foundation, on behalf of their regional ministries.
The President of ASEBIO, Jordi Martí, states that “Our goals with this convention are focused on continuing to consolidate the fair as the benchmark event within the Spanish biotech sector, capable of bringing together all the actors involved: biotechnology and pharmaceutical companies, research institutes, universities, clusters, investors, professional services and consultancies, medical technology companies, engineering companies, etc., and also to enhance the standing of Spain and Andalusia as points of reference in the field of biotechnology and as an excellent place to attract foreign investors. International investors, as well as international companies and entities, can get to know the biotechnology capabilities of Andalusia first hand.”
In the 2016 event, BIOSPAIN attracted 1,750 delegates representing 800 companies from 29 countries, (28% of those attending came from abroad), 233 exhibitors, 50 international investors, 49 breakout sessions and also featured 3,000 one-to-one meetings.
These numbers have made BIOSPAIN the world’s fifth largest biotechnology event by business meetings and the most important country-based event in Europe. The event is structured as a trade fair, a partnering system which facilitates one-to-one meetings, a conference programme and an investor’s forum which brings together the globe’s most important investors from the field of life sciences. As of today, we already have 25 confirmed investors from seven countries, including Ysios Capital Partners, Andera Capital (previously Edmond de Rothschild), Biogeneration Ventures and Johnson & Johnson Innovation.
BIOSPAIN has practically doubled the number of exhibitors, attendees, and companies and has even tripled its number of one-to-one meetings compared with the figures from the 2008 event in Granada. Likewise, the figures show that Andalusia has become one of Spain’s most important regions in the biotech field. According to the data that we will present next week in our ASEBIO 2017 Report, Andalusia is the third largest autonomy community in terms of companies dedicated exclusively to biotechnology, with 16% of the total in Spain, behind Catalonia (23.3%) and Madrid (18.7%), and ahead of the Community of Valencia, with 10%.
Andalusia is also the second largest autonomous community in terms of the number of companies which conduct biotechnology activities regardless of whether it is their principal activity, with 13.5% of the total in Spain. The first is Catalonia with 19.3%. These data serve to reaffirm Andalusia’s firm commitment to biotechnology, with cutting-edge companies and research centers in bioinformatics, agriculture, and the circular economy, among other areas.
This year’s BIOSPAIN programme gives special weight to the biomedical area, although a good part of the conference will also be dedicated to agri-food and industrial biotechnology, mainly in the bioeconomy field. Financing sessions will also have a prominent place. The fair will also feature the plenary speaker Philippe Monteyne, a partner of Fund+. Among the main topics to be discussed in this ninth edition are Alzheimer’s disease, advanced therapies, agri-food, biobanks, financing programmes, circular economy, artificial intelligence, gene editing, immunotherapy, antibiotic resistance, precision medicine, etc.
Additionally, as a new aspect this year, we want to encourage researchers, academics and representatives from intermediary bodies to participate with a special registration policy.
The international presence not only helps the event to grow, but it also enhances the standing of the Spanish market outside of our borders and we contribute to generating new business opportunities in many fields of the economy. The trade fair brings together representatives from biotechnology and pharmaceutical companies, research institutes, universities, clusters, investors, professional services and consultancies, medical technology companies, engineering companies, etc.
In the poll conducted among the participants after finishing the event, 84.81% of those polled in 2016 stated that they identified real business opportunities. The event was classified as good or very good by 76.92% of the people attending.